2015至2018年日本轮状病毒基因型分布:轮状病毒疫苗引入前后基因型的多样性
该研究调查了2015至2018年日本六个地区急性胃肠炎儿童中A组轮状病毒(RVA)基因型的流行与分布,并与疫苗引入前(2006-2012)和引入后(2012-2018)时期进行比较。2015-2018年RVA检出率为19.7%(307/1557);疫苗引入前后平均检出率相近(18%-20%)。疫苗引入后,G1P[8]和G3P[8]等常见基因型检出率下降,而G2P[4]、G2P[8]、G9P[8]和G8P[8]等先前散发基因型出现/再现;作者认为DS-1-like(I2)不寻常株的突然出现值得警惕,持续监测基因型对完善未来疫苗策略必不可少。
要点
- 2015-2018年日本六个地区急性胃肠炎儿童RVA检出率为19.7%(307/1557)。
- 疫苗引入前后RVA平均检出率相近(18%-20%)。
- 疫苗引入后G1P[8]和G3P[8]检出率下降,G2P[4]、G2P[8]、G9P[8]和G8P[8]出现/再现。
核心结论
- 研究呈现了日本轮状病毒疫苗引入前后循环RVA基因型的多样性。
- 疫苗引入后DS-1-like(I2)不寻常株的突然出现值得警惕。
- 持续监测RVA基因型对完善未来疫苗策略必不可少。
研究设计与样本
- 研究从北海道、东京、静冈、大阪、京都和佐贺六个地区的门诊定期采集粪便样本。
- 采用RT-PCR和基于序列的基因分型对RVA进行筛查和基因分型。
- 2015-2018年共检测1557份标本,其中307份(19.7%)RVA阳性。
- 比较疫苗引入前(2006-2012)和引入后(2012-2018)时期的基因型分布。
主要发现
- 2015-2016、2016-2017和2017-2018年度RVA阳性率分别为29.9%(95%CI:25.8%至34.3%)、17.9%(95%CI:14.7%至21.5%)和13%(95%CI:10.3%至16.0%)。
- 疫苗引入前(2006-2012)和引入后(2012-2018)RVA平均检出率几乎相似(18%-20%)。
- 2015-2016年G2P[4]I2最常见(52.1%,95%CI:43.5%-60.6%),2016-2017年G8P[8]I2占主导(55.9%,95%CI:45.2%-66.2%)。
- 2017-2018年G9P[8]I2最流行(42.0%,95%CI:30.5%-53.9%),其次为G9P[8]I1(23.0%,95%CI:14.0%-34.2%)。
- 疫苗引入后G1P[8]和G3P[8]等疫苗前常见基因型检出率下降,而G2P[4]、G2P[8]、G9P[8]和G8P[8]等疫苗前散发基因型出现/再现。
临床怎么用
- 作者认为持续监测RVA基因型对完善未来疫苗策略必不可少。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diversity in group A rotavirus (RVA) strains after introduction of RV-vaccines remains an emerging concern worldwide. In this study, we investigated the prevalence and distribution of RVA genotypes in Japanese children with acute gastroenteritis (AGE) from 2015 to 2018. In addition, a comparison of the genotypes in pre-vaccination (2006-2012) and post-vaccination (2012-2018) periods was conducted to understand the impact of these vaccines on genotype distribution. METHODS: Fecal samples were collected regularly from outpatient clinics in six localities: Hokkaido, Tokyo, Shizuoka, Osaka, Kyoto, and Saga. RVA were screened and genotyped by RT-PCR and sequence-based genotyping. RESULTS: During the period 2015-2018, RVA was detected in 307 (19.7%) samples out of 1557 specimens: 29.9% (95% CI: 25.8% to 34.3%), 17.9% (95% CI: 14.7% to 21.5%), and 13% (95% CI: 10.3% to 16.0%) were detected RVA-positive in 2015-2016, 2016-2017 and 2017-2018, respectively. The average detection of RVA in pre-vaccination (2006-2012) and post-vaccination (2012-2018) era remained almost similar (18%-20%). The G2P[4]I2 (52.1%, 95% CI: 43.5%-60.6%) remained the most common genotype in 2015-2016, whereas G8P[8]I2 (55.9%, 95% CI: 45.2%-66.2%) dominated in 2016-2017. In 2017-2018, G9P[8]I2 (42.0%, 95% CI: 30.5%-53.9%) prevailed, followed by G9P[8]I1 (23.0%, 95% CI: 14.0%-34.2%). The detection rate of some common genotypes of pre-vaccination era like G1P[8] and G3P[8] has been reduced after introduction of RV-vaccine, whereas genotypes that were sporadic before the introduction of vaccines like G2P[4], G2P[8], G9P[8] and G8P[8] were emerged/reemerged in post-vaccination period. CONCLUSIONS: Our study presented the diversity in circulating RVA genotypes in Japan before and after introduction of RV-vaccines. Sudden emergence of DS-1-like (I2) unusual strains in post-vaccination era remains alarming. Continuous monitoring of RVA genotypes is therefore indispensable to refine future vaccine strategy.
引用
- Hoque SA, Khandoker N, Thongprachum A, et al. Distribution of rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes before and after introduction of rotavirus vaccines. Vaccine. 2020. PMID: 32307276. doi:10.1016/j.vaccine.2020.03.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。